comparemela.com

Latest Breaking News On - Prnewswire ardelyx inc - Page 2 : comparemela.com

Ardelyx Provides Update on FDA Appeal for XPHOZAH® (tenapanor) for the Control of Serum Phosphorus in Adult Patients with Chronic Kidney Disease on Dialysis

/PRNewswire/ Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover, develop and commercialize innovative.

United statesPeter steinFosun pharmaDrug administrationArdelyx incPrnewswire ardelyx incOffice of new drugsComplete response letterNew drug applicationNew drugsDrug evaluationKyowa kirinKnight therapeutics

Ardelyx Announces FDA Advisory Committee Votes that the Benefits of XPHOZAH® (tenapanor) Outweigh its Risks for the Control of Serum Phosphorus in Adult Patients with Chronic Kidney Disease on Dialysis

/PRNewswire/ Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover, develop and commercialize innovative.

United statesMike raabSharon moeFosun pharmaIndiana university school of medicineRenal drugs advisory committeeDrug administrationArdelyx incAdvisory committeeOffice of new drugsPrnewswire ardelyx incNew drugsIndiana university schoolDrug evaluationComplete response letterKyowa kirin

National Kidney Foundation and Ardelyx, Inc Survey Finds Dialysis Patients Struggle to Maintain Serum Phosphorus Levels

/PRNewswire/ Ardelyx, Inc. (Nasdaq: ARDX) in partnership with the National Kidney Foundation (NKF), today announced results from a survey of patients with.

Joseph vassalottiLauraa williamsPrnewswire ardelyx incNational kidney foundationArdelyx incArdelyx patient advisory councilPatient advisory councilNational kidney

Ardelyx Reports Third Quarter 2022 Financial Results and Recent Business Highlights

/PRNewswire/ Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover, develop and commercialize innovative.

United statesMike raabSusan lucakFosun pharmaExchange commission onArdelyx incAdvisory committeeExchange commissionCompany annual report on formAmerican college of gastroenterologyPrnewswire ardelyx incJapanese ministry of healthAmerican society of nephrologyKyowa kirin co ltdBusiness highlightsAmerican college

Ardelyx Announces Poster Presentations on XPHOZAH® (tenapanor) at ASN s Kidney Week 2022

/PRNewswire/ Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover, develop and commercialize innovative.

United statesOrange county convention centerFosun pharmaPrnewswire ardelyx incAmerican society of nephrologyKyowa kirin co ltdArdelyx incAmerican societyKidney weekKyowa kirinPoster presentationsPredictive valueEarly responsePatients receiving maintenanceExhibit hallSerum phosphorus

vimarsana © 2020. All Rights Reserved.